Zentiva to discuss Sanofi-Aventis's offer at EGM
This article was originally published in Scrip
Executive Summary
Zentiva's board has called shareholders to the extraordinary general meeting on September 3rd in Amsterdam to discussSanofi-Avenis's offer to buy its shares at a price of CK1,050 ($63.5) each. Earlier the board recommended shareholders to reject this offer (Scrip Online, July 25th, 2008).